05
Mar
Value creation on steroids: Rewriting the playbook
A two-year-old portfolio company transformation plan might be based on assumptions that no longer apply, given the scale of post-pandemic macroeconomic volatility. Inflation has gone up sharply, and then started to come down; capital has become more expensive; and supply chains have been shaken. PE investors responded by reassessing their approaches to value creation, from the management of cash and talent to the application of technology. Industry experts discuss how to generate alpha amid adversity.
- How do strategic priorities change in a longer-than-expected holding period?
- What can investors do to keep their value creation plans on track?
- In which functional areas is it worth developing in-house expertise?
- To what extent is artificial intelligence a tool for operational improvement?
-
SpeakersJames Hindle Partner and Head of Private Equity KPMG AUSTRALIA
Amit Chand Partner POTENTIA CAPITAL
Marcus Darville Managing Partner QUADRANT PRIVATE EQUITY
Nicholas Macksey Partner EQT
Georgina Varley Managing Director ADAMANTEM CAPITAL
Mark Chudek Partner AFFINITY EQUITY PARTNERS
Confirm cancellation
Something went wrong.
An error occurred trying to play the stream. Please reload the page and try again.
CloseSign-up to join the ION Analytics Community to:
- Register for events
- Access market insights
- Download reports